Shih-Chiang Huang, MD

Articles by Shih-Chiang Huang, MD

Although surgery and radiotherapy are standard treatments for localized STS, the role of adjuvant chemotherapy, particularly doxorubicin, in high-grade STS is debated.

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study

ByShiny Chih-Hsuan Wu, MD,Yao-Yu Wu, MD,Chi-Ting Liau, MD,Chih‑Hsiang Chang, MD,Shih-Chiang Huang, MD,Hsin‑Nung Shih, MD,Chun-Chieh Chen, MD, PhD

March 26th 2026

Latest Updated Articles

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study
March 26th 2026

Trending on CancerNetwork

Novel Cancer Vaccine Meets Primary, Secondary End Points in Resected Melanoma

Weighing Bispecific Antibodies Against CAR T Cells in Multiple Myeloma

ccRCC PET Imaging Agent Earns FDA Breakthrough Therapy, Fast Track Statuses

Who Are The Key Candidates to Receive Subcutaneous Amivantamab for HNSCC?

Pembrolizumab/Denosumab Combo Shows Activity in Pretreated ccRCC